A common cholesterol drug fights cataracts, too
February 10, 2010Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men by almost 40%.
"Doctors have known for some time that there is some sort of preventative effect that statins have against cataracts," says Dr. Gabriel Chodick of the Department of Epidemiology and Preventive Medicine at the Sackler Faculty of Medicine at Tel Aviv University, who led the study. "It seems that they protect the eye from inflammation and ocular nerve cells from a process of oxidization. But ours is the first study to show such a strong association in such a large population."
The study covered over 180,000 patients between the years of 1998 and 2007 and was published in the February 2010 issue of the Annals of Epidemiology.
From the heart to the head
Dr. Chodick and his colleague Dr. Varda Shalev found that men aged 45 to 54 who took the statins daily to lower their cholesterol levels also lowered their chances of developing cataracts by 38%. For women of about the same age, the risk for cataracts was also cut dramatically, by about 18%.
Dr. Chodick has been studying the health benefits of statins for years. One of his recent studies, featured as part of a Time magazine cover story, showed that statins can reduce a person's chance of dying from all combined diseases and conditions by 40% -- something in the medical community called "all-cause mortality."
"People who persistently take statins have tremendously reduced chances of premature death by disease. We began to think that statins, which are proven to prevent cardiovascular disease, may do other good things in the body as well. We started investigating cataracts to show statins' effects in a more statistical manner," says Dr. Chodick.
A statin a day...
"Statins are not being taken consistently by patients, and only about 10% of those who get these prescriptions actually end up taking them. Once you start, it's important to continue taking them to avoid cardiovascular problems," Dr. Chodick warns. "But now we have even more good reasons to keep taking statins ― like an apple a day. People who begin taking them in their 40s to early 60s can reap a number of benefits, including better protection against cataracts."
A cataract is a type of clouding that develops in the lens of the eye, leading to varying degrees of sight impairment. It typically progresses slowly so that the sufferer may not even be aware of the problem. If left untreated, a cataract can lead to blindness. In the U.S., cataracts affect about 60% of both men and women over the age of 60. About 1.5 million cataract surgeries are performed in the U.S. each year, and visual disabilities associated with cataracts lead to over 8 million physician office visits a year.
"We believe that the regular use of statins for men and women under the age of 75 can significantly protect them against cataracts," Dr. Chodick concludes. Whether people who are not at risk for heart attacks should take them as a cataract preventative alone has not been determined. But before long we may be taking a daily statin pill along with our daily vitamin tablet, Dr. Chodick believes.
-
Stopping statins after stroke raises risk of death, dependency
Aug 27, 2007 |
not rated yet |
0
-
'Statins' linked to improved survival in kidney transplant recipients
Jul 24, 2008 |
not rated yet |
0
-
Statins shown to lower blood pressure
Apr 14, 2008 |
not rated yet |
0
-
Heart attack patients who stop statin risk death, say researchers
Aug 27, 2008 |
not rated yet |
0
-
Statins increase risk of postoperative delirium in elderly patients
Sep 22, 2008 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Anyone can learn to be more inventive, cognitive researcher says
There will always be a wild and unpredictable quality to creativity and invention, says Anthony McCaffrey, a cognitive psychology researcher at the University of Massachusetts Amherst, because an "Aha moment" is rare and ...
Medicine & Health / Psychology & Psychiatry
2 hours ago |
4.5 / 5 (2) |
0
|
Cell biologists describes mechanism by which some people may be more susceptible to colon cancer
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United ...
3 hours ago |
5 / 5 (1) |
0
|
FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...
Medicine & Health / Neuroscience
6 hours ago |
5 / 5 (27) |
2
|
Researchers weigh in on ethics of H5N1 research
(Medical Xpress) -- In a commentary on the biosecurity controversy surrounding publication of bird flu research details, a bioethicist and a vaccine expert at Johns Hopkins reaffirm that "all scientists have an affirmativ ...
5 hours ago |
not rated yet |
0
|
Focus on self-improvement, rather than winning, benefits young athletes
Underserved youth athletes report more life skill and character development when their coaches place greater emphasis on creating caring climates instead of focusing on competition, according to research from ...
Medicine & Health / Psychology & Psychiatry
2 hours ago |
5 / 5 (1) |
0
'Dark plasmons' transmit energy
Microscopic channels of gold nanoparticles have the ability to transmit electromagnetic energy that starts as light and propagates via "dark plasmons," according to researchers at Rice University.
Ultraviolet protection molecule in plants yields its secrets
Lying around in the sun all day is hazardous not just for humans but also for plants, which have no means of escape. Ultraviolet (UV) radiation from the sun can damage proteins and DNA inside cells, leading ...
Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water
A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...
New method makes culture of complex tissue possible in any lab
Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in ...
Flexible paper robots
(PhysOrg.com) -- These inexpensive robots can stretch, bend and twist under control, and lift objects up to 120 times their own weight. Being soft, they can apply gentle and even pressure, and adapt to varied ...
Deadly bird parasite evolves at exceptionally fast rate
A new study of a devastating bird disease that spread from poultry to house finches in the mid-1990s reveals that the bacteria responsible for the disease evolves at an exceptionally fast rate. What's more, ...
Feb 10, 2010
Rank: not rated yet
Feb 10, 2010
Rank: not rated yet
That carefully hidden number is not a small percentage but over 40% of people taking statins experience muscle problems (including heart muscles) and other serious side effects. This is from an early study where several frustrated Drs. involved in the study released all the testing data after the pharma reported, using tortured data, that only a small percentage of the population experienced serious side effects.
The statins probably work to protect against cataracts by reducing CRP, i.e inflammation.